Skip to main content
. 2015 Jul 15;16(9):1353–1363. doi: 10.1080/15384047.2015.1070987

Table 2.

Ratios of glucose consumption and lactate production after nifurtimox-treatment

  Untreated
50 µg/mL nifurtimox
 
  glucose consumed [*] lactate produced [*] ratio glucose:lactate glucose consumed [*] lactate produced [*] ratio glucose:lactate ratio change
LA-N-1 596 694 1:1.16 or 0.86 378 247 1:0.65 or 1.53
IMR-32 756 386 1:0.51 or 1.96 343 161 1:0.47 or 2.13
LS 728 776 1:1.07 or 0.94 485 188 1:0.39 or 2.56
SK-N-SH 601 293 1:0.49 or 2.06 294 262 1:0.89 or 1.13
*

µM·240 min−1·2,000,000 cells−1.